SAM

On May 27, 2026, the Issuer granted 691 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines.

On May 27, 2026, the Issuer granted 358 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 12, 2027, provided that the non-employee Director remains a member of the Board of Directors as of that date.

The shares reported include 358 shares of restricted stock subject to vesting conditions.

On May 27, 2026, the Issuer granted 358 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 12, 2027, provided that the non-employee Director remains a member of the Board of Directors as of that date.

The shares reported include 358 shares of restricted stock subject to vesting conditions.

On May 27, 2026, the Issuer granted 691 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines.

On May 27, 2026, the Issuer granted 691 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines.

On May 27, 2026, the Issuer granted 358 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 12, 2027, provided that the non-employee Director remains a member of the Board of Directors as of that date.

The shares reported include 358 shares of restricted stock subject to vesting conditions.

On May 27, 2026, the Issuer granted 358 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 12, 2027, provided that the non-employee Director remains a member of the Board of Directors as of that date.

The shares reported include 358 shares of restricted stock subject to vesting conditions.

On May 27, 2026, the Issuer granted 358 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 12, 2027, provided that the non-employee Director remains a member of the Board of Directors as of that date.

The shares reported include 358 shares of restricted stock subject to vesting conditions.

On May 27, 2026, the Issuer granted 691 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines.

On May 27, 2026, the Issuer granted 691 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines.

On May 27, 2026, the Issuer granted 691 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines.

On May 27, 2026, the Issuer granted 358 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 12, 2027, provided that the non-employee Director remains a member of the Board of Directors as of that date.

The shares reported include 358 shares of restricted stock subject to vesting conditions.

The shares reported include 271 shares of restricted stock subject to vesting conditions.

The shares were purchased pursuant to the Issuer's Employee Equity Incentive Plan on March 20, 2026, with an effective grant date of March 1, 2026. Under this plan, tenured employees may purchase restricted shares at a discounted price. These restricted shares vest in five equal installments over a five year period, provided that the Reporting Person remains employed by the Issuer as of the applicable vesting date. The first installment vests one year from the grant date and the final installment vests five years from the grant date. These shares have no expiration date.

The shares reported include 4,012 shares of restricted stock subject to vesting conditions.

Represents grants of Restricted Stock Units ("RSUs") under the Issuer's Restated Employee Equity Incentive Plan ("EEIP"). The details of these grants were disclosed in a Current Report on Form 8-K filed by the Issuer on February 17, 2026.

The shares reported include 11,019 shares of restricted stock subject to vesting conditions.

The Issuer "net withheld" the vesting of a percentage of shares to satisfy the tax obligations of the Reporting Person flowing from the vesting of Restricted Stock Units ("RSUs"). The Reporting Person had a total of 1,006 RSUs vest on March 1, 2026.

The Issuer net withheld the vesting of a percentage of shares to satisfy the tax obligations of the Reporting Person flowing from the vesting of Restricted Stock Units ("RSUs"). The Reporting Person had a total of 914 RSUs vest on March 1, 2026.

The shares reported include 8,541 shares of restricted stock subject to vesting conditions.

The Performance-Based Stock Options were granted pursuant to the Issuer's Employee Equity Incentive Plan ("EEIP") on March 1, 2023. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2024 over Fiscal Year 2022. In February 2025, the Compensation Committee determined that the performance criteria had been achieved, and as such the options will vest in three equal installments on March 1 in the years 2025-2027, contingent on the Reporting Person's continued employment with the Issuer on the applicable vesting dates.

The Performance-Based Stock Options were granted pursuant to the Issuer's Employee Equity Incentive Plan ("EEIP") on March 1, 2023. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2024 over Fiscal Year 2022. In February 2025, the Compensation Committee determined that the performance criteria had been achieved, and as such the options will vest in three equal installments on March 1 in the years 2025-2027, contingent on the Reporting Person's continued employment with the Issuer on the applicable vesting dates.

The Issuer net withheld the vesting of a percentage of shares to satisfy the tax obligations of the Reporting Person flowing from the vesting of Restricted Stock Units ("RSUs"). The Reporting Person had a total of 1,293 RSUs vest on March 1, 2026.

The shares reported include 9,465 shares of restricted stock subject to vesting conditions.

Represents grants of Restricted Stock Units ("RSUs") under the Issuer's Restated Employee Equity Incentive Plan ("EEIP"). The details of these grants were disclosed in a Current Report on Form 8-K filed by the Issuer on February 17, 2026.

The shares reported include 3,183 shares of restricted stock subject to vesting conditions.

Represents grants of Restricted Stock Units ("RSUs") under the Issuer's Restated Employee Equity Incentive Plan ("EEIP"). The details of these grants were disclosed in a Current Report on Form 8-K filed by the Issuer on February 17, 2026.

The shares reported include 2,322 shares of restricted stock subject to vesting conditions.

The Issuer net withheld the vesting of a percentage of shares to satisfy the tax obligations of the Reporting Person flowing from the vesting of Restricted Stock Units ("RSUs"). The Reporting Person had a total of 498 RSUs vest on March 1, 2026.

The Issuer net withheld the vesting of a percentage of shares to satisfy the tax obligations of the Reporting Person flowing from the vesting of Restricted Stock Units ("RSUs"). The Reporting Person had a total of 944 RSUs vest on March 1, 2026.

Represents grants of Restricted Stock Units ("RSUs") under the Issuer's Restated Employee Equity Incentive Plan ("EEIP"). The details of these grants were disclosed in a Current Report on Form 8-K filed by the Issuer on February 17, 2026.

The shares reported include 23,097 shares of restricted stock subject to vesting conditions.

The Time-Based Stock Option was granted pursuant to the Issuer's EEIP on October 31, 2023. The shares will vest in four equal installments on March 1 in the years 2024-2027 provided that the Reporting Person remains employed by the Issuer on the applicable vesting dates, and subject to accelerated vesting in certain situations.

Represents grants of Restricted Stock Units ("RSUs") under the Issuer's Restated Employee Equity Incentive Plan ("EEIP").

The shares reported include 3,763 shares of restricted stock subject to vesting conditions. A total of 650 RSUs and 83 investment shares vested on March 1, 2026.

The Time-Based Stock Option was granted pursuant to the Issuer's EEIP on May 15, 2023. The options vest in four equal installments on March 1 in the years 2024-2027, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations.

The Issuer net withheld the vesting of a percentage of shares to satisfy the tax obligations of the Reporting Person flowing from the vesting of Restricted Stock Units ("RSUs"). The Reporting Person had a total of 288 RSUs vest on March 1, 2026.

The Issuer net withheld the vesting of a percentage of shares to satisfy the tax obligations of the Reporting Person flowing from the vesting of Restricted Stock Units ("RSUs"). The Reporting Person had a total of 2,116 RSUs vest on March 1, 2026.

The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2023. In February 2025, the Compensation Committee determined that the performance criteria had been achieved. The options vest in three equal installments on March 1 in the years 2025-2027, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations.

The Issuer net withheld the vesting of a percentage of shares to satisfy the tax obligations of the Reporting Person flowing from the vesting of Restricted Stock Units ("RSUs"). The Reporting Person had a total of 3,811 RSUs vest on March 1, 2026.

The shares reported include 30,378 shares of restricted stock subject to vesting conditions.

Represents grants of Restricted Stock Units ("RSUs") under the Issuer's Restated Employee Equity Incentive Plan ("EEIP"). The details of these grants were disclosed in a Current Report on Form 8-K filed by the Issuer on February 17, 2026.

The shares reported include 11,012 shares of restricted stock subject to vesting conditions.

The Performance-Based Stock Options were granted pursuant to the Issuer's Employee Equity Incentive Plan ("EEIP") on March 1, 2023. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2024 over Fiscal Year 2022. In February 2025, the Compensation Committee determined that the performance criteria had been achieved, and as such the options will vest in three equal installments on March 1 in the years 2025-2027, contingent on the Reporting Person's continued employment with the Issuer on the applicable vesting dates.

The Stock Option was granted pursuant to the Issuer's Equity Plan for Non-Employee Directors on May 25, 2016. The options were immediately exercisable and were scheduled to expire on May 25, 2026.

The price shown is the weighted average sale price for the transactions reported on this line. The range of sale prices for the 1,968 shares is from $205.75 to $206.50. The Filing Person will provide full information regarding the number of shares sold at each separate price upon request of the SEC, the Registrant, or a shareholder of the Registrant.

The price shown is the weighted average sale price for the transactions reported on this line. The range of sale prices for the 1,152 shares is from $204.67 to $205.61. The Filing Person will provide full information regarding the number of shares sold at each separate price upon request of the SEC, the Registrant, or a shareholder of the Registrant.

The shares reported include 10,673 shares of restricted stock subject to vesting conditions.

The time-based option vests in three tranches on January 1 in each of the years 2026 through 2028, provided that the Reporting Person remains employed by the Issuer on the applicable vesting dates.

Represents a grant of a time-based RSUs under the Issuer's Employee Equity Incentive Plan. The RSUs will vest in three tranches on January 1 in each of the years 2026 through 2028, subject to the Reporting Person's continued employment with the Company on that date.

The shares reported include 38,584 shares of restricted stock subject to vesting conditions.

Represents a grant of Restricted Stock Units ("RSUs") under the Issuer's Employee Equity Incentive Plan. 100% of the RSUs will vest on August 11, 2026, contingent upon the Reporting Person's continued employment by the Company on that date.

Represents a grant of Restricted Stock Awards (RSUs) under the Issuer's Employee Equity Incentive Plan, which awards were granted in conjunction with the the cancellation of the Reporting Person's May 24, 2023 stock option awards. The grant is comprised of two sets of awards: a time-based RSU and a performance based RSU. The time-based RSU is for 9,197 shares and will vest in three tranches, with the final vesting on March 1, 2027 subject to the Reporting Person's continued employment with the Company on that date. The performance-based RSU is for 4,599 shares and is subject to the same performance criteria and vesting schedule as his previous May 24, 2023 stock option award, as disclosed in a Current Report on Form 8-K filed by the Issuer on May 22, 2023.

The shares reported include 29,997 shares of restricted stock subject to vesting conditions.

The price shown is the weighted average sale price for the transactions reported on this line. The range of sale prices for the 136 shares is from $219.53 to $219.94. The Filing Person will provide full information regarding the number of shares sold at each separate price upon request of the SEC, the Registrant, or a shareholder of the Registrant.

The shares reported include 9,455 shares of restricted stock subject to vesting conditions.

The price shown is the weighted average sale price for the transactions reported on this line. The range of sale prices for the 464 shares is from $218.53 to $219.50. The Filing Person will provide full information regarding the number of shares sold at each separate price upon request of the SEC, the Registrant, or a shareholder of the Registrant.

The shares reported include 9,455 shares of restricted stock subject to vesting conditions.

On May 14, 2025, the Issuer granted 546 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines.

On May 14, 2025, the Issuer granted 271 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 13, 2026, provided that the non-employee Director remains a member of the Board of Directors as of that date.

The shares reported include 271 shares of restricted stock subject to vesting conditions.

On May 14, 2025, the Issuer granted 546 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines.

On May 14, 2025, the Issuer granted 271 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 13, 2026, provided that the non-employee Director remains a member of the Board of Directors as of that date.

The shares reported include 271 shares of restricted stock subject to vesting conditions.

On May 14, 2025, the Issuer granted 271 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 13, 2026, provided that the non-employee Director remains a member of the Board of Directors as of that date.

The shares reported include 271 shares of restricted stock subject to vesting conditions.